Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of YM543 in Type 2 Diabetes
NCT00454233Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of YM543 in type 2 diabetes mellitus (T2DM), sponsored by Astellas Pharma. Started Feb 2007; status: completed.
02
Drugs
YM543
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00454233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454233.